A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate Cancer

Running, not enrolling

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to see if a telemedicine group doctor's appointment is a practical (feasible) and acceptable method for following people with prostate cancer being managed with active surveillance when compared with the usual approach of individual telemedicine visits, which involve the participant visiting a doctor on their own. The researchers will compare the telemedicine group and individual visits by measuring on participant satisfaction and quality of life in each type of visit. Telemedicine is the use of secure video technology on a desktop computer, laptop, smartphone, or tablet to provide and receive healthcare from a distance.

Key facts

Study ID

NCT05416996

Run by

Memorial Sloan Kettering Cancer Center

People needed

88

Starts

2022-06-05

Expected to finish

2027-06-01

Last updated by the study team

2026-07-21

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• A scheduled appointment for a subsequent Active Surveillance (AS) follow-up visit for management of localized prostate cancer
• Biopsy Gleason score 3+3=6 (Grade Group 1) or biopsy Gleason score 3+4=7 (Grade Group 2)
• Clinical T stage ≤T2B
• Access to a device with Zoom
• Ability to speak and understand English

You may not qualify if…

• Plan to undergo a prostate biopsy at this follow-up visit

Where it is running

• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.